The effects of topical coenzyme Q10 and vitamin e d-α-tocopheryl polyethylene glycol 1000 succinate after cataract surgery: A clinical and in vivo confocal study

Ophthalmologica

Volumn 229, Issue 1, 2012, Pages 26-31

  Fogagnolo, Paolo ^a,c   Sacchi, Matteo ^b   Ceresara, Gaia ^b   Paderni, Ruggiero ^b   Lapadula, Paolo ^b   Orzalesi, Nicola ^b   Rossetti, Luca ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

Author keywords

Cataract surgery; Coenzyme Q10; Cornea; Ocular surface; Subbasal nerve plexus

Indexed keywords

COQUN; SODIUM CHLORIDE; TOCOFERSOLAN; UBIDECARENONE; UBIDECARENONE PLUS TOCOFERSOLAN; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BURNING SENSATION; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IN VIVO STUDY; MALE; NERVE PLEXUS; NERVE REGENERATION; POSTOPERATIVE CARE; SCHIRMER TEST; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; AGED; CATARACT EXTRACTION; DRUG CARRIERS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICROSCOPY, CONFOCAL; OPHTHALMIC SOLUTIONS; POLYETHYLENE GLYCOLS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UBIQUINONE; VITAMIN E; VITAMINS; WOUND HEALING;

EID: 84871609951     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000342196     Document Type: Article

References (26)

1. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone f unction. Biochim Biophys Acta 1995; 1271: 195-204.
2. 10 in cardiovascular disease. Mitochondrion 2007; 7(suppl):S154-S167.
3. 10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 2007; 21:297-306.
4. 10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 1997; 18 (s u p p l) : S159-S168.
5. 10 and nicotin-amide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 1994; 36: 882-888.
6. Beal MF: Mitochondrial dysfunction in neu-rodegenerative diseases. Biochim Biophys Acta 1998; 1366: 211-223.
7. 10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci 2002; 22: 1592-1599.
8. 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998; 95:8892-8897.
9. 10) on muscular dystrophies and neurogen-ic atrophies. Biochim Biophys Acta 1995; 1271: 281-286.
10. 10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002; 59: 1541-1550.
11. 10 in patients with Parkinson's disease. Exp Neu-rol 2004; 188: 491-494.
12. Walker FO, Raymond LA: Targeting energy metabolism in Huntington's disease. Lancet 2004; 364:312-313.
13. 10 therapy. Biofactors 2003; 18: 163-171.
14. Muller LJ, Marfurt CF, Kruse F, et al: Cor-neal nerves: structure, contents and function. Exp Eye Res 2003; 76:521-542.
15. Dartt DA: Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul Surf 2004; 2:76-91.
16. Perez-Santonja JJ, Sakla H, Cardona C, et al: Corneal sensitivity after photorefractive keratectomy and laser in situ keratomileusis for low myopia. Am J Ophthalmol 1999; 127: 497-504.
17. Martin XY, Safran AB: Corneal hypoesthe-sia. Surv Ophthalmol 1988; 33:28-40.
18. Oliveira-Soto L, Efron N: Morphology of corneal nerves using confocal microscopy. Cornea 2001; 20: 374-384.
19. Chylack LT Jr, Leske MC, McCarthy D, Khu P, Kashiwagi T, Sperduto R: Lens opacities classification system II (LOCS II). Arch Ophthalmol 1989; 107: 991-997.
20. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL: Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118:615-621.
21. Babu K, Narasimha Murthy K, Ramachan-dra Murthy K: Wavelike epitheliopathy after phacoemulsification: role of in vivo confocal microscopy. Cornea 2007; 26: 747-748.
22. De Cillà S, Ranno S, Carini E, et al: Corneal subbasa l ner ves changes in patients with diabetic retinopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci 2009; 50: 5155-5158.
23. Patel SV, McLaren JW, Hodge DO, Bourne WM: Confocal microscopy in vivo in corneas of long-term contact lens wearers. Invest Ophthalmol Vis Sci 2002; 43: 995-1003.
24. Martone G, Frezzotti P, Tosi GM, et al: An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 2009; 147:725-735.
25. Ranno S, Fogagnolo P, Rossetti L, Orzalesi N, Nucci P: Changes in corneal parameters at confocal microscopy in treated glaucoma patients. Clin Ophthalmol 2011; 5:1037-1042.
26. Darwish T, Brahma A, Efron N, O'Donnell C: Subbasal nerve regeneration after penetrating keratoplasty. Cornea 2007; 26: 935-940.